RecruitingPhase 3NCT05473520
Doxycycline Host-directed Therapy to Improve Lung Function and Decrease Tissue Destruction in Pulmonary Tuberculosis
Studying Tuberculosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- National University Hospital, Singapore
- Principal Investigator
- Catherine Ong, MRCP PhDNational University Hospital, Singapore
- Intervention
- Doxycycline(drug)
- Enrollment
- 150 enrolled
- Eligibility
- 21 years · All sexes
- Timeline
- 2023 – 2030
Study locations (6)
- Hospital Queen Elizabeth I, Kota Kinabalu, Sabah, Malaysia
- Klinik Kesihatan Luyang, Kota Kinabalu, Sabah, Malaysia
- Klinik Kesihatan Menggatal, Kota Kinabalu, Sabah, Malaysia
- Universiti Malaysia Sabah (UMS), Borneo Medical and Health Research Centre, Kota Kinabalu, Sabah, Malaysia
- National University Hospital, Singapore, Singapore
- TB Control Unit, Singapore, Singapore
Collaborators
Tan Tock Seng Hospital · Hospital Queen Elizabeth, Malaysia · National University of Singapore · University Malaysia Sabah · Menggatal Health Clinic, Sabah, Malaysia · Luyang Health Clinic, Sabah, Malaysia
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05473520 on ClinicalTrials.govOther trials for Tuberculosis
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07164742Parent Study Name: Pulmonary Rehabilitation to Reduce Post-Tuberculosis Morbidity (TB Pure)Johns Hopkins University
- RECRUITINGNCT0707721318F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) in Tuberculosis PatientsChildren's Hospital Medical Center, Cincinnati
- ENROLLING BY INVITATIONNANCT06984887Evaluation of New TB Diagnostic Tests (NATs) in PakistanMercy Corps Pakistan
- RECRUITINGNCT07018076Candidate Clinical Correlate of Prognostic Outcome for TB StudyUniversity of California, San Francisco
- RECRUITINGNANCT07271225Safety and Efficacy of Ear Acupuncture for Antituberculosis Drug-Related Nausea and VomitingIndonesia University
- RECRUITINGNCT06585358DoseTB-individualised Dosing by Model-informed Precision Dosing for Pulmonary TuberculosisKarolinska Institutet
- RECRUITINGPHASE3NCT06497465Dolutegravir/Lamivudine Dual Therapy for ART-naïve People With HIV and TB Receiving Rifampin-based TB TreatmentJohns Hopkins University
- RECRUITINGNCT07178860Respiratory Health and Wellbeing Post Pulmonary TuberculosisLiverpool School of Tropical Medicine